ZA200701798B - Derivatives of arylsulfonamido-substituted hydroxamic acid as matrix metalioproteinases inhibitors - Google Patents

Derivatives of arylsulfonamido-substituted hydroxamic acid as matrix metalioproteinases inhibitors

Info

Publication number
ZA200701798B
ZA200701798B ZA200701798A ZA200701798A ZA200701798B ZA 200701798 B ZA200701798 B ZA 200701798B ZA 200701798 A ZA200701798 A ZA 200701798A ZA 200701798 A ZA200701798 A ZA 200701798A ZA 200701798 B ZA200701798 B ZA 200701798B
Authority
ZA
South Africa
Prior art keywords
arylsulfonamido
derivatives
hydroxamic acid
inhibitors
substituted hydroxamic
Prior art date
Application number
ZA200701798A
Other languages
English (en)
Inventor
Bertini Ivano
Fragai Marco
Lo Conte Mauro
Luchinat Claudio
Nativi Cristina
Venturi Chiara
Original Assignee
Abiogen Pharma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abiogen Pharma Spa filed Critical Abiogen Pharma Spa
Publication of ZA200701798B publication Critical patent/ZA200701798B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/22—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms
    • C07C311/29—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C311/16—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
    • C07C311/19—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom to an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • C07H3/02—Monosaccharides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pyrane Compounds (AREA)
  • Lubricants (AREA)
ZA200701798A 2004-08-03 2007-02-28 Derivatives of arylsulfonamido-substituted hydroxamic acid as matrix metalioproteinases inhibitors ZA200701798B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT000174A ITFI20040174A1 (it) 2004-08-03 2004-08-03 Derivati arilsolfonammidici dell'acido idrossammico ad azione inibitoria di metalloproteinasi

Publications (1)

Publication Number Publication Date
ZA200701798B true ZA200701798B (en) 2008-08-27

Family

ID=35787488

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200701798A ZA200701798B (en) 2004-08-03 2007-02-28 Derivatives of arylsulfonamido-substituted hydroxamic acid as matrix metalioproteinases inhibitors

Country Status (14)

Country Link
US (2) US7772430B2 (ja)
EP (2) EP2308837A3 (ja)
JP (1) JP2008509108A (ja)
CN (1) CN101076514A (ja)
AT (1) ATE492530T1 (ja)
AU (1) AU2005268765B2 (ja)
BR (1) BRPI0514030A (ja)
CA (1) CA2580235A1 (ja)
DE (1) DE602005025495D1 (ja)
IT (1) ITFI20040174A1 (ja)
MX (1) MX2007001269A (ja)
RU (2) RU2406721C2 (ja)
WO (1) WO2006013193A2 (ja)
ZA (1) ZA200701798B (ja)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011528013A (ja) 2008-07-14 2011-11-10 ノバルティス アーゲー ヒドロキサム酸系の選択的ｍｍｐ−１２およびｍｍｐ−１３阻害剤
DE102011088926A1 (de) * 2011-12-19 2013-06-20 Beiersdorf Ag Haarstylingformulierung zur Erstellung eines flexiblen Haltes durch Einsatz von Octanohydroxamsäure
CN104245717B (zh) * 2011-12-28 2017-10-24 卡莱克汀医疗有限公司 用于治疗人类疾病的新型糖类药物的组合物
EP2907512A1 (en) 2014-02-14 2015-08-19 Commissariat A L'energie Atomique Et Aux Energies Alternatives Inhibitors of MMP-12 as antiviral Agents
CN105728047B (zh) * 2016-03-24 2017-12-26 万华化学集团股份有限公司 一种氢甲酰化催化剂及其制备方法和应用
JP2017210442A (ja) * 2016-05-26 2017-11-30 イノレックス インベストメント コーポレイション マトリックスメタロプロテイナーゼを阻害して皮膚の老化を軽減する方法及び関連の相乗的組成物
IT201600083975A1 (it) * 2016-08-09 2018-02-09 Consorzio Interuniversitario Naz Per La Scienza E Tecnologia Dei Materiali Acido ialuronico funzionalizzato
JP6541118B1 (ja) * 2018-04-27 2019-07-10 株式会社成和化成 化粧品基材および該化粧品基材を含有する毛髪用化粧品、美白剤
LV15485B (lv) * 2018-09-13 2020-06-20 Latvijas Organiskās Sintēzes Institūts Selenofēnhromenonu hidroksāmskābes, to izgatavošana un izmantošana angioģenēzes inhibīcijā

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU68901A1 (ja) 1973-11-30 1975-08-20
US5506242A (en) * 1993-01-06 1996-04-09 Ciba-Geigy Corporation Arylsufonamido-substituted hydroxamic acids
US5455258A (en) * 1993-01-06 1995-10-03 Ciba-Geigy Corporation Arylsulfonamido-substituted hydroxamic acids
NZ325939A (en) * 1996-01-23 2000-06-23 Shionogi & Co Sulphonated amino acid derivatives and matrix metalloproteinase inhibitors (MMP) containing these derivatives
EP0915086A4 (en) * 1996-05-24 2001-01-17 Ono Pharmaceutical Co PHENYLSULFONAMIDE DERIVATIVES
ES2171905T3 (es) * 1996-10-22 2002-09-16 Upjohn Co Acidos alfa-amino sulfonilo hidroxamicos como inhibidores de metaloproteinasa de matriz.
PL335027A1 (en) * 1997-02-03 2000-03-27 Pfizer Prod Inc Derivatives of arylsulphonylamino hydroxamic acid
AU7294098A (en) * 1997-05-09 1998-11-27 Agouron Pharmaceuticals, Inc. Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses
CA2298617A1 (en) * 1997-07-31 1999-02-11 Yetunde Olabisi Taiwo Acyclic metalloprotease inhibitors
JPH11199512A (ja) * 1997-10-24 1999-07-27 Pfizer Prod Inc 変形性関節症および他のｍｍｐ媒介疾患の治療のためのｍｍｐ−１３選択的阻害剤の使用
PA8469601A1 (es) * 1998-04-10 2000-09-29 Pfizer Prod Inc Procedimiento para alquilar sulfonamidas impedidas estericamente
CN1331674A (zh) * 1998-12-22 2002-01-16 霍夫曼-拉罗奇有限公司 磺酰胺异羟肟酸酯
WO2000038645A1 (de) 1998-12-28 2000-07-06 Celanese Ventures Gmbh Verwendung von wasserunlöslichen linearen poly-alpha-glucan als uv-filter
FR2799964B1 (fr) 1999-10-22 2002-07-26 Oreal Emulsions contenant au moins un filtre uv organique insoluble et un polymere associatif
WO2001085124A1 (en) 2000-05-10 2001-11-15 Ciba Specialty Chemicals Holding Inc. Silylated compounds as precursors for self-tanning compositions
GB0028161D0 (en) 2000-11-17 2001-01-03 Natural Environment Res Personal care compositions
FR2827860B1 (fr) * 2001-07-24 2004-12-10 Servier Lab Nouveau procede de synthese de derives de l'acide (2s, 3as, 7as)-1-[(s)-alanyl]-octahydro-1h-indole-2-carboxyline et application a la synthese du perindopril
DE10155200A1 (de) 2001-11-12 2003-05-28 Skinlab Gmbh Verwendung von Cholesterin, cholesterinhaltigen Substanzen oder von den Cholesteringehalt erhöhenden Substanzen in kosmetischen und dermatologischen Zubereitungen zum Zwecke der UV-Protektion
DE10155769A1 (de) 2001-11-14 2003-05-22 Cognis Deutschland Gmbh Kosmetische und/oder pharmazeutische Emulsionen
DK1511472T3 (da) * 2002-05-29 2009-08-24 Merck & Co Inc Anvendelige forbindelser til behandling af Anthrax og hæmning af letalfaktor

Also Published As

Publication number Publication date
DE602005025495D1 (de) 2011-02-03
US20100298439A1 (en) 2010-11-25
ITFI20040174A1 (it) 2004-11-03
EP2308837A3 (en) 2011-04-20
RU2010136061A (ru) 2012-03-10
CA2580235A1 (en) 2006-02-09
EP1781601A2 (en) 2007-05-09
WO2006013193A3 (en) 2006-08-31
BRPI0514030A (pt) 2008-05-27
AU2005268765B2 (en) 2011-08-04
WO2006013193A8 (en) 2010-07-29
MX2007001269A (es) 2007-07-16
EP1781601B1 (en) 2010-12-22
RU2406721C2 (ru) 2010-12-20
WO2006013193A2 (en) 2006-02-09
CN101076514A (zh) 2007-11-21
RU2007107872A (ru) 2008-09-10
AU2005268765A1 (en) 2006-02-09
JP2008509108A (ja) 2008-03-27
US20080249032A1 (en) 2008-10-09
EP2308837A2 (en) 2011-04-13
ATE492530T1 (de) 2011-01-15
US7772430B2 (en) 2010-08-10

Similar Documents

Publication Publication Date Title
ZA200701798B (en) Derivatives of arylsulfonamido-substituted hydroxamic acid as matrix metalioproteinases inhibitors
ES2330291A1 (es) Peptidos utiles en el tratamiento de la piel, mucosas y/o cuero cabelludo y su uso en composiciones cosmeticas o farmaceuticas.
MX2011008616A (es) Peptidos utiles en el tratamiento y/o cuidado de la piel , mucosas y/o cuero cabelludo y su uso en composiciones cosmeticas o farmaceuticas.
MX337830B (es) Peptidos utiles en el tratamiento y/o cuidado de la piel y/o cabello y su uso en composiciones cosmeticas o farmaceuticas.
MX2012004625A (es) Peptidos utiles en el tratamiento y/o cuidado de la piel, mucosas y/o cabello y su uso en composiciones cosmeticas o farmaceuticas.
WO2007070850A3 (en) Skin care compositions and treatments
EP1592665A4 (en) HISTONE DEACETYLASE INHIBITORS OF NEW POWERFUL DIFFERENTIATION BENZAMIDE DERIVATIVES WITH PROLIFERATION-INHIBITING ACTIVITY
NZ539841A (en) Hydroxyethylamine derivatives for the treatment of alzheimer's disease
MY119231A (en) Novel lipoic acid derivatives, their preparation, and pharmaceutical compositions containing them
MXPA06000660A (es) Uso de una composicion cosmetica o farmaceutica que comprende un extracto rico en lupeol, como un ingrediente activo para estimular la sintesis de proteinas de choque termico.
ZA202202376B (en) Difluorohaloallylamine sulfone derivative inhibitors of lysyl oxidases, methods of preparation, and uses thereof
WO2008004165A3 (en) Use of c-glycoside derivatives as pro-desquamating active agents
NO20075433L (no) Harvann
MXPA05014184A (es) Utilizacion de acido hialuronico para la preparacion de composiciones para el tratamiento de aftas en la cavidad oral.
US20190021976A1 (en) Composition for preventing, improving or treating photoaging of skin comprising dhpv
WO2004100893A3 (en) Methods for treatment of inflammatory diseases using ct-3 or analogs thereof
AU2003226709A1 (en) Organosilicone derivatives of amino hydroxybenzophenones and their use as uv-a filters in cosmetic preparations
US9750677B2 (en) Use of metal complexes which are mimetics of SOD as food agents and as cosmetics
MX2009012712A (es) Nuevas 4-fenil-imidazol-2-tionas como inhibidores de la tirosinasa, su procedimiento de preparacion y su uso en medicina humana asi como en cosmetica.
MX2009012714A (es) Nuevas 4-heteroail-imidazol-2-tionas como inhibidores de la tirosinasa, su procedimiento de preparacion y su uso en medicina humana asi como en cosmetica.
WO2011015758A3 (fr) Utilisation de n-hexadecanoyl isoleucine comme agent "volumateur" et/ou comme agent "repulpant" de la peau humaine
TW200505916A (en) 7-azaindoles and the use thereof as therapeutic agents
TW200505448A (en) 5-hydroxyindoles with n-oxide groups and the use thereof as therapeutic agents
WO2006103119A3 (en) Tyrosinase inhibitors, process for the preparation thereof and use thereof in human medicine and also in cosmetics
TW200503693A (en) 4-, 6- or 7-hydroxyindoles with n-oxide groups and the use thereof as therapeutic agents